1 Introduction Gastric cancer is the third most frequent cause of cancer-related death, and the fifth most diagnosed malignancy around the world ( Helicobacter pylori ( H
From 1st week: Reduced pain (noticeable within 3-7 days) Decreased inflammation Improved range of motion Better sleep (reduced pain at night) By week 2-3: Significant pain reduction Return to light activity possible Improved tissue mobility Reduced morning stiffness Week 4-6: Major healing progress Return to normal activities for minor injuries Continued improvement for moderate injuries Tissue strength improving Week 6-8: Near complete recovery for minor injuries Significant improvement for moderate injuries Reduced risk of re-injury Can increase activity level safely Realistic expectations: BPC-157 might cut healing time by 30-50%
While oral administration peaks at approximately 220-300 micromoles per liter due to intestinal transport saturation, vitamin C injections can achieve concentrations exceeding 15,000 micromoles per literrepresenting a 70-fold increase over oral bioavailability
Diseases such as Alzheimers, dementia, sarcopenia, arthritis, Parkinsons, osteoporosis, maculopathy, COPD, and cancer increase with advancing age (Franceschi et al 2018)
Notably, those early reports touted BPC-157 as free of side effects with a very safe profile, even at high doses